[
  {
    "question": "Patient with tongue deviation to the left side and ptosis in his left upper eyelid, what is the artery involved?",
    "option_a": "ICA",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "D",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "This question tests knowledge of brainstem vascular territories. A patient presenting with ipsilateral tongue deviation implies a lesion of the hypoglossal nerve (CN XII) or its nucleus in the medulla, and ipsilateral ptosis suggests disruption of sympathetic fibers, often seen in Horner syndrome. These findings together point toward a combined medullary involvement that is typically seen with a vertebral artery insult. The vertebral artery and its branches supply both the medial and lateral parts of the medulla. Infarction in this region can affect the hypoglossal nucleus (resulting in tongue deviation toward the lesion) and the adjacent descending sympathetic fibers (leading to ptosis as part of Horner syndrome). This pattern may result from vertebral artery dissection or thrombosis compromising both the paramedian branches (feeding the medial medulla) and the branches (such as PICA, which supplies the lateral medulla) when the occlusion is proximal enough to affect both territories. Clinically, patients may present with tongue deviation toward the side of the lesion due to ipsilateral hypoglossal nerve involvement, while ptosis is a hallmark of associated Horner syndrome. This constellation of signs should prompt imaging workup for medullary infarction, with attention to the vertebral artery. Initial evaluation involves non-contrast CT to rule out hemorrhage, followed by MRI with diffusion\u2010weighted imaging and vascular imaging (MRA, CTA, or DSA) to confirm an infarct and assess the integrity of the vertebral artery. Differential diagnoses include isolated medial medullary syndrome (usually from anterior spinal artery occlusion) and lateral medullary (Wallenberg) syndrome, but the combined features point toward vertebral artery pathology. Acute management follows standard ischemic stroke protocols: rapid neuroimaging, consideration of thrombolysis or endovascular intervention (if within the therapeutic window), and aggressive management of vascular risk factors. In cases of vertebral artery dissection, antithrombotic therapy (anticoagulants or antiplatelets) is indicated. In pregnant or lactating women, treatment decisions are made cautiously; intravenous thrombolysis may be considered if the benefits outweigh risks, and antithrombotic agents with established safety profiles in pregnancy (e.g., low-dose aspirin) might be used. Option A (ICA) is incorrect as the internal carotid artery supplies the anterior circulation and does not primarily supply the medulla. The marked answer D implies the vertebral artery, which is the correct vessel implicated as it supplies the medullary regions containing both the hypoglossal nucleus and the descending sympathetic fibers. 1. Ipsilateral tongue deviation indicates a lesion of the hypoglossal nucleus or nerve; 2. Ptosis in the setting of brainstem stroke should prompt consideration of an associated Horner syndrome from lateral medullary involvement; 3. Combined medial and lateral medullary signs are highly suggestive of vertebral artery pathology. Recent studies underscore the importance of early vascular imaging in brainstem strokes. Advances in endovascular treatments and refined criteria for thrombolysis are improving outcomes in vertebral artery-related strokes. Current stroke guidelines emphasize detailed evaluation of the posterior circulation, especially in cases demonstrating mixed medullary findings.",
    "exam_year": "2020",
    "exam_type": "Part I"
  },
  {
    "question": "Brain CT showing right SCA territory infarction (level of midbrain) and asked about the artery",
    "option_a": "SCA",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "This question focuses on the identification of the vascular territory involved in a midbrain infarction seen on CT. The Superior Cerebellar Artery (SCA) supplies not only portions of the cerebellum but also parts of the midbrain, making it the target vessel in SCA territory infarctions. Occlusion of the SCA, which originates from the basilar artery near the rostral pons, can lead to infarction of the superior aspect of the cerebellum and nearby midbrain structures. This disruption of blood flow results in localized ischemia and consequent neurological deficits. Patients with SCA territory infarction may present with ataxia, dysmetria, and sometimes ocular motor disturbances if adjacent midbrain structures are compromised. The CT finding localizes the infarct to the SCA territory at the level of the midbrain, correlating with these clinical findings. After an initial non-contrast CT to exclude hemorrhage, MRI with diffusion-weighted imaging provides better detail of the infarction. Vascular imaging such as MRA or CTA is used to confirm occlusion of the SCA. Differential diagnoses include infarctions in adjacent territories such as the posterior cerebral artery (PCA) territory, but the CT localization helps narrow the diagnosis. Management of SCA infarcts follows standard ischemic stroke guidelines: prompt reperfusion therapy (if within the window), supportive care, and secondary prevention with antithrombotic therapy and risk factor modification. In pregnant or lactating patients, thrombolytics may be used with careful consideration of maternal and fetal risks, and antiplatelet agents with safety data in pregnancy are preferred. Option A, which identifies the Superior Cerebellar Artery as the vessel involved, is correct. Other potential options (not provided) would involve vessels not supplying this region (e.g., posterior cerebral or anterior inferior cerebellar arteries), making Option A the best choice in this scenario. 1. The SCA supplies the rostral cerebellum and parts of the midbrain; 2. Infarction in this territory can lead to cerebellar ataxia and coordination deficits; 3. Accurate vascular localization on imaging is key to guiding appropriate management. Current stroke guidelines recommend detailed imaging of the posterior circulation in suspected SCA infarcts. Emerging endovascular techniques and improved MRI protocols are enhancing early diagnosis and management of these less common strokes.",
    "exam_year": "2020",
    "exam_type": "Part I",
    "image_url": "page_6.png"
  },
  {
    "question": "74-year-old male with CT brain image showing large hemorrhage in the cortex what to do next",
    "option_a": "(MRI): Though MRI (especially with SWI) is sensitive for detecting microbleeds and cavernous malformations, it is not the first",
    "option_b": "(CTA): CTA is a rapid, non",
    "option_c": "(Conventional angiography",
    "option_d": "",
    "option_e": "",
    "correct_answer": "c",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "This question addresses the appropriate next step in the evaluation of a large cortical hemorrhage in a 74-year-old male, with suspicion for an underlying vascular malformation (e.g., cerebral angiodysplasia). The stepwise diagnostic process is critical for planning further therapeutic interventions. A large cortical hemorrhage in an elderly patient may be due to rupture of abnormal vascular structures such as arteriovenous malformations (AVMs) or cavernous malformations. The vulnerability of these malformed vessels to bleeding necessitates detailed vascular imaging to delineate the lesion\u2019s architecture and hemodynamics. Clinically, patients with cortical hemorrhages may present acutely with focal neurological deficits, headache, or seizures. When imaging reveals a cortical bleed, it is important to consider vascular malformations as a cause, especially in the absence of other risk factors such as severe hypertension. Initial evaluation begins with a non-contrast CT to identify hemorrhage. While MRI (with specialized sequences like SWI) and CTA can provide additional information, conventional digital subtraction angiography (DSA) remains the gold standard for detailed visualization of cerebral vasculature, particularly in the assessment of complex vascular malformations. Differential diagnoses include hypertensive hemorrhage, amyloid angiopathy, or hemorrhagic transformation of an ischemic stroke, but the cortical location raises suspicion for an underlying malformation. Once a vascular malformation is identified, management may include endovascular embolization, surgical resection, or radiosurgery, guided by the lesion\u2019s size, location, and vascular supply. In the acute setting, managing intracranial pressure and stabilizing the patient are priorities. For pregnant or lactating patients, imaging modalities that minimize radiation exposure are preferred; however, if DSA is indicated, appropriate shielding and risk\u2013benefit analysis must be performed, as maternal neurological stability is paramount. \u2022 Option a (MRI): Though MRI (especially with SWI) is sensitive for detecting microbleeds and cavernous malformations, it is not the first-line test in the emergent evaluation of a large cortical hemorrhage due to limited availability and potential to miss high-flow abnormalities. \n\u2022 Option b (CTA): CTA is a rapid, non-invasive method but may not detect all subtleties of small or complex vascular malformations. \n\u2022 Option c (Conventional angiography - DSA): This option is correct because DSA is the gold standard, providing high-resolution and dynamic imaging necessary for detailed assessment of the lesion and for planning therapeutic interventions. 1. In cortical hemorrhages, always consider an underlying vascular malformation; 2. DSA remains the definitive imaging technique for complex cerebrovascular evaluations; 3. Quick and accurate vascular assessment guides appropriate management and improves outcomes. Recent guidelines and studies have reinforced the use of DSA in cases of lobar hemorrhage with suspicion for vascular malformations. Emerging techniques in interventional neuroradiology continue to improve the safety and efficacy of endovascular treatments following DSA-based diagnosis.",
    "exam_year": "2020",
    "exam_type": "Part I",
    "image_url": "page_27.png"
  },
  {
    "question": "Patient post MVA came with symptoms of lateral medullar, mechanism of stroke?",
    "option_a": ", which posits a mechanism involving vertebral artery injury leading to artery",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "a",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "This question evaluates understanding of the mechanism of stroke following trauma, specifically in the context of lateral medullary syndrome. The lateral medulla is most commonly affected by occlusion of the Posterior Inferior Cerebellar Artery (PICA), which itself is often compromised secondary to vertebral artery injury. In patients following a motor vehicle accident (MVA), trauma can lead to injury of the vertebral artery. Such injury can result in dissection or intimal damage that promotes thrombus formation. The resulting artery-to-artery embolism can lodge in the branches of the vertebral artery (notably PICA) and cause ischemia in the lateral medulla, producing the classic symptoms of lateral medullary (Wallenberg) syndrome. Patients with lateral medullary syndrome typically present with a constellation of symptoms such as dysphagia, hoarseness, vertigo, ataxia, and loss of pain and temperature sensation on the ipsilateral face with contralateral body involvement. In the context of trauma, the mechanism of vertebral artery injury is highly relevant in explaining these clinical manifestations. Diagnosis involves neuroimaging. CT and MRI help localize the infarct, while vascular imaging (CTA, MRA, or DSA) is essential to demonstrate vertebral artery injury and possible dissection. Differential diagnoses include cardioembolism, small vessel disease (typically causing lacunar infarcts), and venous thrombosis, but in trauma, vertebral artery dissection is most consistent with the presentation. Management includes stabilizing the patient, antithrombotic therapy (anticoagulation or antiplatelet therapy) to prevent further embolism, and close monitoring of neurological status. In cases of vertebral artery dissection, conservative management is often preferred. For pregnant and lactating patients, therapeutic choices should consider both maternal and fetal safety; for instance, low molecular weight heparin is often used due to its safety profile in pregnancy. Option a, which posits a mechanism involving vertebral artery injury leading to artery-to-artery thrombus formation, is correct. Other mechanisms such as cardioembolism, small vessel disease, or venous thrombosis are less consistent with the trauma-induced scenario and the specific vascular distribution of the lateral medulla. 1. Lateral medullary syndrome (Wallenberg syndrome) is classically due to occlusion of PICA; in trauma, this is most often secondary to vertebral artery dissection. 2. Early vascular imaging is key in trauma patients to identify vertebral artery injury. 3. Management with antithrombotic therapy can prevent further embolic events in cases of arterial dissection. Recent literature emphasizes the importance of early recognition and treatment of vertebral artery dissection in the setting of trauma. Updated guidelines support the use of antithrombotic therapy and detailed vascular imaging (preferably DSA in complex cases) to guide management and improve outcomes in patients with lateral medullary syndrome.",
    "exam_year": "2020",
    "exam_type": "Part I"
  },
  {
    "question": "Acute stroke With CT image with no established stroke ASPECT 8? Was treated with tPA CTA done and prepared for thrombectomy then he vomited (increase ICP \u2192 (ICH)?) and become lethargic bp 180/110",
    "option_a": "",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "C",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "When managing an acute stroke patient who has received tPA, any sudden neurological deterioration must be evaluated immediately with imaging to determine complications, especially hemorrhagic transformation. The core concept is to use imaging as a decision-making tool before altering therapeutic measures. Thrombolytic therapy can predispose patients to hemorrhagic transformation due to reperfusion injury. Vomiting and lethargy may indicate raised intracranial pressure secondary to bleeding. Additionally, high blood pressure can exacerbate hemorrhage by increasing the transmural capillary pressure, further compromising the blood-brain barrier. In the described case, the patient\u2019s sudden deterioration (vomiting and lethargy) following tPA is highly concerning for hemorrhage. The clinical scenario necessitates a rapid, non\u2010contrast CT scan to distinguish between hemorrhagic transformation, malignant edema, or other complications. The immediate diagnostic step is to obtain a non-contrast head CT to confirm or exclude intracranial hemorrhage. Differential diagnoses include hemorrhagic transformation (the most likely in this context), malignant cerebral edema post-stroke, or other intracranial events. Prompt imaging is vital to guide further interventions such as ceasing tPA or implementing controlled blood pressure reduction. Based on the latest guidelines, after tPA administration, any clinical worsening should prompt an urgent CT scan. Once hemorrhage is confirmed, tPA must be stopped, and blood pressure should be managed carefully. Subsequent treatment may include reversal agents if available, neurosurgical consultation, and strict blood pressure control. In pregnant or lactating women, the benefits of rapid imaging and intervention outweigh potential risks; however, radiation exposure should be minimized with appropriate shielding if possible. Option (c) advocating for an immediate CT scan is the correct initial action. Option (b) (stopping tPA) and option (a) (decreasing blood pressure) are both important but should only be executed after imaging confirmation to avoid inappropriate management that might worsen ischemic injury. The marked answer (D) is therefore incorrect as it does not address the immediate diagnostic need. 1. Neurological deterioration post-tPA mandates immediate non-contrast CT imaging to rule out hemorrhagic transformation. 2. Blood pressure and tPA management adjustments should be guided by imaging findings. 3. Timely diagnosis is crucial to modify therapy and prevent further complications. Recent studies and updated guidelines from the AHA/ASA emphasize the importance of prompt imaging to guide management in post-thrombolysis patients. Emerging evidence supports that immediate CT scanning improves outcomes by confirming the diagnosis of hemorrhage and ensuring targeted subsequent interventions.",
    "exam_year": "2020",
    "exam_type": "Part I"
  },
  {
    "question": "Patient with small left internal capsule infarction and right-sided weakness (not minor stroke) for 2 days found to have PFO (not mentioned if there was a specific feature of it) HTN with uncontrolled BP. What is the treatment?",
    "option_a": "",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "a",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "Aspirin is a well-established first-line antiplatelet agent for secondary prevention in ischemic stroke, particularly in strokes resulting from small vessel disease (lacunar strokes). Aspirin works by irreversibly inhibiting cyclooxygenase-1 (COX-1), leading to a reduction in thromboxane A2 synthesis, thereby preventing platelet aggregation that can cause further ischemic events. In this patient, the small left internal capsule infarct with right-sided weakness is consistent with a lacunar stroke, typically attributable to small vessel disease exacerbated by uncontrolled hypertension. Aspirin reduces the risk of subsequent strokes by minimizing platelet aggregation. Differential diagnoses include cardioembolic stroke, large artery atherosclerosis, and small vessel (lacunar) infarcts. Clinical assessment and imaging help differentiate these entities; for example, cardioembolic strokes may require echocardiography while lacunar strokes correlate with risk factors like hypertension. Guidelines for secondary prevention in lacunar stroke recommend starting with aspirin as a single antiplatelet agent along with aggressive risk factor control (hypertension, diabetes, hyperlipidemia). For patients who are pregnant or lactating, low-dose aspirin is generally considered safe after a risk\u2013benefit evaluation. Option (a) Aspirin is correct as it is first-line for lacunar strokes. Option (b) Warfarin is not indicated since there is no evidence of cardioembolism. Option (c) PFO closure is reserved for cryptogenic strokes with high-risk PFO features absent in this case. Option (d) Dual antiplatelet therapy is typically used short-term in minor stroke or TIA scenarios, not for a non-minor lacunar stroke. 1. Lacunar strokes, typically related to small vessel disease, are best managed with single antiplatelet therapy. 2. Effective blood pressure control is critical in secondary prevention. 3. Aspirin\u2019s anti-thrombotic properties are key to reducing the recurrence of ischemic events. Recent guidelines from AHA/ASA reinforce single antiplatelet therapy (aspirin) for secondary stroke prevention in small vessel disease. Studies continue to demonstrate that the benefits of aspirin outweigh the risks in lacunar strokes, with dual antiplatelet therapy reserved for specific short-term indications.",
    "exam_year": "2020",
    "exam_type": "Part I"
  },
  {
    "question": "Case of stroke with intracranial stenosis what to do?",
    "option_a": "DAPT",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "In cases of stroke associated with intracranial stenosis, dual antiplatelet therapy (DAPT) is a cornerstone strategy to prevent recurrent embolic events by targeting multiple platelet activation pathways. Intracranial atherosclerotic disease leads to stenosis, increasing the risk of cerebral ischemia due to reduced blood flow and embolic phenomena. DAPT (typically aspirin plus clopidogrel) reduces platelet aggregation and subsequent thrombus formation, lowering the risk of recurrent stroke. Patients with intracranial stenosis have a high risk for recurrent ischemic events. Initiating DAPT in the immediate post-stroke period has been shown to reduce the incidence of further strokes, especially in the critical early phase. Intracranial stenosis is diagnosed with vascular imaging modalities such as CT angiography, MR angiography, or digital subtraction angiography. Differential diagnoses include extracranial carotid stenosis and cardioembolic sources, which are differentiated through comprehensive clinical and imaging evaluations. Current guidelines recommend starting DAPT (aspirin and clopidogrel) for patients with symptomatic intracranial stenosis for about 90 days, in conjunction with aggressive risk factor management including statins and blood pressure control. For pregnant or lactating patients, low-dose aspirin is often considered acceptable; however, clopidogrel must be used with caution and only if clearly indicated. Option (A) DAPT is correct as it aligns with current best practices for reducing recurrent stroke risk in patients with intracranial stenosis. Other options, not provided here, might include single antiplatelet therapy or anticoagulation, which are less effective in this context. 1. DAPT is most beneficial in the first 90 days following a stroke attributed to intracranial stenosis. 2. Aggressive risk factor modification is essential for long-term stroke prevention. 3. Imaging confirmation of stenosis is crucial for guiding therapy. Recent trials such as SAMMPRIS have supported the use of DAPT in patients with symptomatic intracranial stenosis. Updated guidelines continue to emphasize a combination of dual antiplatelet therapy and intensive medical management to decrease the risk of recurrent events.",
    "exam_year": "2020",
    "exam_type": "Part I"
  },
  {
    "question": "Patient has stroke with slurred speech you referred him to speech therapist and rehab service, this is considered as:",
    "option_a": "",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "c",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "Prevention strategies in stroke are classified into three categories: primary (preventing the first event), secondary (preventing recurrence), and tertiary (minimizing disability and enhancing recovery post-event). Referral to rehabilitation services falls under tertiary prevention. Tertiary prevention focuses on improving functional outcomes and reducing long-term disability through rehabilitative measures. Neuroplasticity plays a key role as targeted therapies help the brain reorganize in response to injury. For a patient with slurred speech post-stroke, referral to a speech therapist and rehabilitation services is aimed at reducing impairments and improving quality of life. This intervention targets restoration of lost function and compensation strategies. The clinical scenario clearly differentiates from primary and secondary prevention. Primary prevention involves measures before any stroke occurs, and secondary prevention focuses on preventing additional strokes. In contrast, tertiary prevention addresses the consequences of a stroke. Current guidelines support early and comprehensive rehabilitation for stroke survivors. A multi-disciplinary approach including physical, occupational, and speech therapy is recommended. For pregnant or lactating patients, rehabilitative programs should be adapted to ensure maternal and fetal safety while maximizing recovery. Option (a) Primary prevention is incorrect as it applies to preventing the first stroke. Option (b) Secondary prevention targets preventing recurrence rather than rehabilitating deficits. Option (c) Tertiary prevention is correct because it involves addressing the impairments after the stroke. Option (d) is not applicable. 1. Early rehabilitation is essential in improving post-stroke outcomes. 2. Tertiary prevention minimizes long\u2010term disability and enhances functional recovery. 3. Multi-disciplinary care is key in comprehensive stroke recovery. Recent research highlights the effectiveness of early, intensive rehabilitation in promoting neuroplasticity and improving functional outcomes. Updated guidelines continue to recommend structured rehabilitation programs as an integral part of post-stroke care.",
    "exam_year": "2020",
    "exam_type": "Part I"
  },
  {
    "question": "Case of press female with high BP 180/?? Presented with seizure and confusion with MRI showing bilateral occipital cortical hyperintensity dx",
    "option_a": "(PRES) is correct because the clinical presentation of severe hypertension, seizures, confusion, and the MRI findings of bilateral occipital hyperintensities are classic for PRES. Other options like ischemic stroke, infectious encephalitis, or demyelinating disease would not typically present with these bilateral, symmetrical imaging features combined with the acute hypertensive setting.",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "a",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "Posterior reversible encephalopathy syndrome (PRES) is an acute neurological disorder characterized by vasogenic edema predominantly affecting the posterior cerebral regions. It typically occurs in the setting of abrupt blood pressure elevations, eclampsia, or exposure to certain immunosuppressive drugs. PRES results from a breakdown of cerebral autoregulation. The sudden rise in blood pressure overwhelms the vessels' ability to constrict, leading to hyperperfusion and extravasation of fluid into the interstitial space, primarily in the parieto-occipital regions. This manifests on MRI as symmetric hyperintensities on T2/FLAIR sequences. In cases of pregnancy such as pre-eclampsia/eclampsia, similar mechanisms apply, further emphasizing the syndrome\u2019s ties to hypertensive emergencies. Clinically, patients present with headache, seizures, visual disturbances, confusion, and sometimes focal neurological deficits. The classic neuroimaging finding is bilateral, predominantly occipital cortical hyperintensities corresponding to vasogenic edema. These features help distinguish PRES from conditions like ischemic stroke or encephalitis. The diagnosis is primarily based on clinical history (e.g., severe hypertension, exposure to causative agents) combined with MRI findings. Differential diagnoses include ischemic stroke (typically focal and with diffusion restriction), infectious encephalitis (often accompanied by fever and CSF abnormalities), and demyelinating disorders (which have a subacute course with different lesion patterns). First-line management centers on prompt blood pressure lowering with agents sensitive to patient context. In pregnant or lactating women, antihypertensives like labetalol, hydralazine, and nifedipine are preferred due to their safety profiles. Seizure management with antiepileptics (e.g., levetiracetam) may be necessary. Secondary management includes treatment of the precipitating cause (e.g., eclampsia or renal dysfunction). Option A (PRES) is correct because the clinical presentation of severe hypertension, seizures, confusion, and the MRI findings of bilateral occipital hyperintensities are classic for PRES. Other options like ischemic stroke, infectious encephalitis, or demyelinating disease would not typically present with these bilateral, symmetrical imaging features combined with the acute hypertensive setting. 1. PRES is often reversible if blood pressure is promptly controlled. 2. Visual disturbances are common due to the posterior cerebral involvement. 3. Always consider PRES in hypertensive emergencies, especially in obstetric patients. Recent studies and guidelines continue to emphasize early diagnosis with MRI and rapid blood pressure management to prevent permanent deficits. Ongoing research into the pathophysiology of blood-brain barrier disruption in PRES is enhancing therapeutic strategies.",
    "exam_year": "2020",
    "exam_type": "Part I"
  },
  {
    "question": "Picture of skin rash (Angiokeratomas) with history of father death due to a stroke and asked about the gene",
    "option_a": "Alpha-galactosidase A",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "Fabry disease is an X-linked lysosomal storage disorder caused by a deficiency of the enzyme alpha-galactosidase A. This enzymatic defect leads to the accumulation of glycosphingolipids, particularly globotriaosylceramide (Gb3), in various tissues. The deficiency in alpha-galactosidase A results in progressive accumulation of Gb3 in the vascular endothelium, kidneys, heart, and skin. The deposition in dermal capillaries causes the formation of angiokeratomas, while accumulation in cerebral vasculature increases the risk of early stroke. Skin findings such as angiokeratomas\u2014small, dark red to black papules\u2014are hallmarks of Fabry disease. Additionally, patients can present with acroparesthesias, hypohidrosis, corneal verticillata, and an increased risk of cardiovascular and cerebrovascular events. A family history of early stroke further supports the diagnosis. The diagnosis is confirmed by measuring alpha-galactosidase A enzyme activity and genetic testing for mutations in the GLA gene. Differential diagnoses might include other metabolic or vascular skin disorders, but the systemic involvement and enzyme assay help direct the diagnosis. First-line treatment involves enzyme replacement therapy (ERT) to reduce Gb3 accumulation. Adjunctive therapies include pain management and interventions for renal or cardiac complications. In pregnancy and lactation, while data are limited, ERT has been used with caution under close specialist supervision, ensuring minimal risk to both mother and fetus. Option A (Alpha-galactosidase A) is correct as it is the gene responsible for the production of the enzyme deficient in Fabry disease. Other options would not correlate with the genetic defect seen in this condition. 1. Angiokeratomas are an early and key diagnostic clue in Fabry disease. 2. Even heterozygous females can exhibit symptoms due to X-linked inheritance variability. 3. Early initiation of ERT can slow the progression of organ damage. Recent guidelines advocate for early diagnosis with enzyme assays and genetic testing. Advances in treatment, including pharmacological chaperones and gene therapy, are under investigation, promising improved outcomes in the future.",
    "exam_year": "2020",
    "exam_type": "Part I"
  },
  {
    "question": "Patient with progressive myoclonus and dementia how to confirm the diagnosis",
    "option_a": "nalysis indicates that Option A (MRI) is the most appropriate diagnostic test for confirming the diagnosis of PME by demonstrating neurodegenerative changes. Assessments of lactate or invasive muscle biopsy are not first",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "Progressive myoclonus epilepsies (PME) comprise a heterogeneous group of neurodegenerative disorders characterized by action myoclonus, seizures, and cognitive decline. Accurate diagnosis relies on a combination of clinical evaluation and neuroimaging. PME disorders are typically associated with progressive neuronal loss and cortical atrophy. These changes are often detectable on brain MRI, which may reveal cortical and cerebellar atrophy corresponding to the clinical manifestations of myoclonus and dementia. Patients with PME present with gradually worsening myoclonic jerks, seizures, and cognitive impairment. MRI findings corroborate the clinical severity by showing brain atrophy and other characteristic patterns that differentiate PME from other neurodegenerative conditions. The most appropriate initial diagnostic modality is MRI, which helps visualize brain atrophy and other structural changes. Although genetic testing is definitive, MRI serves as a critical first step. Differential diagnoses include mitochondrial disorders, metabolic encephalopathies, and other causes of dementia, but their imaging profiles are distinct (e.g., lactate peaks in mitochondrial disorders). Management is largely symptomatic, including the use of antiepileptic drugs (such as valproate and levetiracetam) for seizure control. There is no curative treatment; intervention focuses on improving quality of life and providing supportive care. In pregnant and lactating patients, careful choice of antiepileptic medications is crucial due to teratogenic potential and drug safety profiles. Although the original marked answer was D, the option analysis indicates that Option A (MRI) is the most appropriate diagnostic test for confirming the diagnosis of PME by demonstrating neurodegenerative changes. Assessments of lactate or invasive muscle biopsy are not first-line tests in this context. 1. MRI is a rapid, non-invasive tool essential for the early detection of neurodegenerative changes in PME. 2. A detailed family history enhances diagnostic accuracy in suspected genetic epilepsies. 3. Following imaging, genetic testing is crucial for a definitive diagnosis. Current research supports the role of MRI as an invaluable screening tool in PME. Advances in genetic testing techniques are increasingly aiding in the precise categorization of these disorders, although MRI remains the cornerstone of initial evaluation.",
    "exam_year": "2020",
    "exam_type": "Part I"
  },
  {
    "question": "Case about Kearns Sayre and asked about the mutation",
    "option_a": "Sporadic large mitochondrial DNA deletion",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "Kearns-Sayre syndrome (KSS) is a mitochondrial cytopathy characterized by a classic triad: progressive external ophthalmoplegia, pigmentary retinopathy, and the onset of symptoms before the age of 20. It is a multi-system disorder affecting tissues with high-energy demands. KSS is caused by sporadic, large-scale deletions in mitochondrial DNA, which lead to defective energy production in affected cells. This mitochondrial dysfunction preferentially affects muscles and the nervous system, including ocular and cardiac tissues. Patients typically present with ptosis, ophthalmoplegia, and retinal pigmentary changes, along with possible conduction abnormalities and endocrine dysfunction. These features align well with the underlying mitochondrial defect. Confirmation of KSS is achieved via genetic testing demonstrating large, sporadic mitochondrial DNA deletions. Differential considerations include other forms of mitochondrial myopathy and neuromuscular disorders, but the combination of ophthalmoplegia, retinopathy, and conduction issues is characteristic of KSS. Management is primarily supportive. Cardiac conduction defects require regular monitoring and may necessitate pacemaker insertion. Other supportive treatments involve addressing endocrine abnormalities and using co-factors like coenzyme Q10. In pregnancy and lactation, careful counseling and monitoring are essential, given the risk of mitochondrial transmission; however, most cases of KSS are sporadic and do not follow a classical maternal inheritance pattern. Option A, specifying a sporadic large mitochondrial DNA deletion, is correct because it accurately reflects the genetic etiology of KSS. Other options would not account for the typical mitochondrial deletion seen in this syndrome. 1. KSS usually manifests before age 20 with a classic triad that includes ophthalmoplegia and pigmentary retinopathy. 2. Pay special attention to cardiac conduction abnormalities as they can necessitate urgent intervention. 3. Genetic counseling is important, especially in familial cases, despite the sporadic nature of the deletions. Recent studies continue to support the role of mitochondrial DNA analysis in confirming KSS. Management guidelines emphasize regular cardiac screening and multidisciplinary supportive care, with ongoing research into targeted therapies for mitochondrial disorders.",
    "exam_year": "2020",
    "exam_type": "Part I"
  },
  {
    "question": "An engineer patient diagnosed with Huntington disease, telling you not to tell his employee?",
    "option_a": "Send his employee an email",
    "option_b": "hide genetic test",
    "option_c": "record him as he\u2019s having other diagnoses",
    "option_d": "respect him and record that on file",
    "option_e": "",
    "correct_answer": "D",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "This question tests your understanding of patient confidentiality and the ethical duty to respect a patient\u2019s wishes regarding the disclosure of sensitive genetic information. Huntington disease is a neurodegenerative disorder that carries significant social and employment implications, so the patient\u2019s autonomy and privacy must be maintained. Huntington disease is caused by an autosomal dominant mutation\u2014a CAG trinucleotide repeat expansion in the huntingtin (HTT) gene. The abnormal protein product leads to neuronal dysfunction and degeneration (especially in the caudate nucleus), but the molecular pathology does not lessen the need for strict confidentiality. An engineer receiving a diagnosis of Huntington disease may worry about potential employment discrimination or stigma. The ethical challenge arises when a patient explicitly states that he does not want his employer to be informed about his diagnosis. This scenario is not uncommon when dealing with genetic or stigmatizing diagnoses. While the diagnosis is established clinically and by genetic testing, the approach to handling such sensitive information revolves around strict adherence to confidentiality rules. Differential considerations might include conditions that mimic Huntington disease (such as other choreas), but here the focus is on ethical documentation rather than additional testing. The current management underscores multidisciplinary care, including neurologic evaluation, psychiatric support, and genetic counseling. Management of confidentiality is guided by ethical principles outlined in the AMA Code of Medical Ethics and HIPAA regulations. For patients who are pregnant or lactating, genetic counseling is essential as these conditions may impact family planning and require careful discussion of risks without breaching confidentiality. Option A (sending an email to his employee) violates confidentiality; Option B (hiding the genetic test) mismanages medical records and transparency; Option C (recording another diagnosis) is both unethical and inaccurate. Option D (respecting his wishes and noting this in the chart) is correct as it adheres to confidentiality and documentation principles. 1. Always prioritize patient confidentiality, especially with stigmatizing genetic diseases. 2. Document the patient\u2019s wishes clearly in the medical record. 3. Recall that ethical principles trump unwarranted disclosure, even when third parties might be affected. The latest ethical guidelines from the AMA and HIPAA emphasize patient autonomy and confidentiality. Recent discussions in medical ethics also highlight the importance of nondisclosure unless the patient gives explicit consent, particularly in the era of increased genetic testing.",
    "exam_year": "2021",
    "exam_type": "Part I"
  },
  {
    "question": "Girl with (migraine head, stroke and dementia), and family history of similar issues in her father. What is your diagnosis?",
    "option_a": "CADASIL",
    "option_b": "MELAS",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "This question is designed to evaluate your knowledge of hereditary vascular disorders of the brain. A patient (in this case, a girl) presenting with migraine, stroke, and dementia along with a family history (affected father) is characteristic of a specific genetic small vessel disease. CADASIL (Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy) is caused by mutations in the NOTCH3 gene. The resulting abnormality leads to degeneration of vascular smooth muscle cells and accumulation of granular osmiophilic material, which in turn causes multiple subcortical infarcts and eventual cognitive decline. Patients with CADASIL often present with migraine-like headaches (commonly with aura), recurrent subcortical ischemic events, and early-onset dementia. The autosomal dominant inheritance (often with a paternal history) helps distinguish it from other hereditary conditions like MELAS, which follows a maternal pattern. The diagnosis is supported by brain MRI findings (white matter hyperintensities involving the temporal poles and subcortical regions) and confirmed by genetic testing. Differential diagnoses include MELAS (characterized by stroke-like episodes and lactic acidosis, with maternal inheritance) and other causes of early stroke in young patients. There is no curative treatment for CADASIL. Management typically involves addressing vascular risk factors (blood pressure control, smoking cessation), symptomatic management of migraines, and supportive care for cognitive decline. In pregnant or lactating women, medication choices (such as anti-migraine drugs) require an assessment of teratogenic risks, with non-teratogenic options preferred. Option A correctly identifies CADASIL. Option B (MELAS) is less likely due to differences in inheritance patterns (mitochondrial inheritance with maternal transmission) and clinical features, making it the incorrect choice. 1. CADASIL should be considered in younger patients with a combination of migraine, stroke, and cognitive decline with a positive family history. 2. MRI findings (especially anterior temporal lobe involvement) are key to diagnosis. 3. Always consider the inheritance pattern when evaluating genetic disorders. Recent guidelines emphasize early diagnosis via MRI and genetic testing in suspected CADASIL cases. Ongoing research looks into targeted therapies, but current management remains largely supportive and symptomatic.",
    "exam_year": "2021",
    "exam_type": "Part I"
  },
  {
    "question": "Patient came with a ct brain attached, asked about which artery? \u0645\u0643\u0631\u0631",
    "option_a": "",
    "option_b": ", which we assume represents the artery shown on the CT image (commonly the MCA is invoked in such questions). Options corresponding to other arteries (ACA, PCA, etc.) are incorrect based on the imaging findings. Without the full list, we infer that Option B best matches the territory demonstrated on the provided CT.",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "This question involves the interpretation of a CT brain image to identify the vascular territory involved. Knowledge of cerebral arterial anatomy and the typical imaging appearances of infarcts in various arterial territories is key to answering this question. Ischemic strokes are generally categorized based on the artery that is occluded. Each cerebral artery supplies a distinct region of the brain. For instance, an occlusion of the Middle Cerebral Artery (MCA) is the most common and typically produces infarcts in the lateral hemispheric region. The underlying mechanism involves thrombotic or embolic events leading to tissue infarction in the territory supplied by the culprit artery. Clinically, an infarct in the MCA territory may present with contralateral weakness, sensory loss, or aphasia (if the dominant hemisphere is involved). CT imaging, typically performed acutely, is crucial to rule out hemorrhage and to help localize the infarcted region which correlates with the vascular territory. The differential diagnosis includes infarcts in the territories of the anterior cerebral artery (ACA), posterior cerebral artery (PCA), and other less common vessels. The CT imaging characteristics, coupled with clinical findings, help differentiate among these. Advanced imaging (CT angiography or MRI) can further delineate the vascular anatomy. Immediate management follows established stroke protocols (e.g., the \u201ctime is brain\u201d approach). First-line treatments include intravenous thrombolysis when indicated, and mechanical thrombectomy in eligible patients. In pregnant or lactating women, decisions regarding thrombolytic therapy should carefully weigh maternal benefits versus fetal risks, with current guidelines providing specific recommendations on the safe use of such interventions during pregnancy. Although the options are not fully detailed, the marked answer is Option B, which we assume represents the artery shown on the CT image (commonly the MCA is invoked in such questions). Options corresponding to other arteries (ACA, PCA, etc.) are incorrect based on the imaging findings. Without the full list, we infer that Option B best matches the territory demonstrated on the provided CT. 1. The MCA is the most commonly involved artery in ischemic strokes. 2. CT brain imaging is the cornerstone of initial stroke evaluation to exclude hemorrhage and to assess infarct location. 3. Rapid identification of the vascular territory guides immediate therapeutic decisions. Recent stroke guidelines stress the importance of early CT imaging and prompt reperfusion therapy. Ongoing research continues to refine criteria for thrombolysis and thrombectomy, including in special populations such as pregnant patients, ensuring that the latest protocols are followed.",
    "exam_year": "2021",
    "exam_type": "Part I"
  },
  {
    "question": "Same Q as above, asked about genes?",
    "option_a": "CAG trinucleotide repeat",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "This question assesses your knowledge of the genetic basis of a neurodegenerative disorder. The option 'CAG trinucleotide repeat' is most classically associated with Huntington disease, which is characterized by a progressive degeneration of neurons and specific radiologic findings (such as caudate atrophy). Huntington disease is caused by an expansion of the CAG trinucleotide repeat in the Huntingtin (HTT) gene. This mutation leads to the production of an abnormal protein that accumulates within neurons, particularly in the caudate nucleus and putamen, causing cell death and resulting in a spectrum of neuropsychiatric and motor disturbances. The clinical presentation typically includes choreiform movements, cognitive decline, and psychiatric symptoms. Imaging studies (MRI or CT) often reveal atrophy of the caudate nucleus with ex vacuo dilation of the lateral ventricles. Genetic testing demonstrating an expanded CAG repeat confirms the diagnosis. The definitive diagnosis is made through genetic testing that quantifies the number of CAG repeats. Differential diagnoses might include other trinucleotide repeat disorders (e.g., spinocerebellar ataxias), but the clinical picture and pattern of atrophy help pinpoint Huntington disease. There is no cure for Huntington disease; management is symptomatic and supportive. This includes medications for chorea (such as tetrabenazine or deutetrabenazine), psychiatric care, and occupational therapy. For pregnant or lactating women, treatment decisions require careful consideration of fetal exposure risks, and genetic counseling is crucial for family planning. Option A, 'CAG trinucleotide repeat', is the correct answer because it directly relates to the genetic mutation found in Huntington disease. Other options (not provided) would depict alternative genetic mutations not associated with this disorder. 1. Huntington disease is characterized by progressive neurodegeneration with prominent caudate atrophy on imaging. 2. The genetic mutation involves an expansion of CAG repeats in the HTT gene \u2013 more repeats correlate with earlier onset (anticipation). 3. Early genetic counseling is essential for patients and their families when facing this diagnosis. Recent research in Huntington disease focuses on targeted molecular therapies including antisense oligonucleotides and other gene-silencing approaches. Current guidelines stress symptomatic management and the importance of multidisciplinary care, with ongoing trials examining potential disease-modifying therapies.",
    "exam_year": "2021",
    "exam_type": "Part I"
  },
  {
    "question": "Female patient came with ischemic stroke, history of previous 2 abortions, elevated prothrombin time. what to investigate?",
    "option_a": "Antiphospholipid syndrome",
    "option_b": "Prothrombin Gene Mutation",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "Antiphospholipid syndrome (APS) is an autoimmune prothrombotic disorder that frequently presents in young women with a history of recurrent pregnancy losses and thrombotic events such as stroke. The antibodies produced in APS interfere with phospholipid-dependent coagulation tests, creating a paradox where laboratory tests demonstrate prolonged clotting times while the patient remains at high risk for thrombosis. APS is mediated by autoantibodies (e.g., lupus anticoagulant, anticardiolipin, and anti-\u03b22 glycoprotein I) that bind to plasma proteins associated with phospholipids, leading to endothelial cell activation, platelet aggregation, and an increased production of tissue factor. This results in a hypercoagulable state and explains both the thrombotic events, such as stroke, and the recurrent spontaneous abortions seen in these patients. Despite the in vitro prolongation of tests like the activated partial thromboplastin time, the in vivo state is one of increased clotting. A young female presenting with an ischemic stroke alongside a history of two abortions should prompt consideration of APS. The recurrent pregnancy loss, in the setting of abnormal clotting tests, fits the classic description of APS, making it the prime suspect in such a clinical scenario. Diagnosis is established by demonstrating the persistence of antiphospholipid antibodies on two occasions at least 12 weeks apart. Differential diagnoses include other thrombophilic conditions such as the prothrombin gene mutation and Factor V Leiden mutation, but the strong association of APS with obstetric complications helps in differentiating APS from these other conditions. Management of APS involves long-term anticoagulation to prevent further thrombotic events. For non-pregnant patients, vitamin K antagonists (e.g., warfarin) with INR goals tailored to risk are standard. In pregnant patients, warfarin is contraindicated due to teratogenicity; instead, a combination of low molecular weight heparin (LMWH) and low-dose aspirin is recommended. LMWH is also considered safe during lactation. Option A (Antiphospholipid syndrome) is correct because the clinical scenario (ischemic stroke with a history of recurrent abortions and abnormal clotting values) is highly suggestive of APS. Option B (Prothrombin Gene Mutation) is less favored as it is not as strongly linked to recurrent pregnancy losses as APS. 1. In young women with stroke and a history of recurrent miscarriages, always consider APS. 2. Laboratory tests may show prolonged clotting times paradoxically in a prothrombotic state. 3. Confirmatory antibody tests should be repeated 12 weeks apart for a definitive diagnosis. Recent guidelines, including those from the American College of Rheumatology and European League Against Rheumatism, reinforce the importance of both clinical and laboratory criteria for diagnosing APS and emphasize individualized anticoagulant strategies, especially in pregnancy where LMWH is preferred.",
    "exam_year": "2021",
    "exam_type": "Part I"
  },
  {
    "question": "Case scenario of a post RTA patient with brain stem symptoms and findings, asked about mechanism?",
    "option_a": "Artery to artery",
    "option_b": "Cardioembolic",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "Post-traumatic brainstem symptoms following a road traffic accident (RTA) should raise concern for vascular injuries in the vertebrobasilar system. Traumatic dissections of cervical arteries, such as the vertebral arteries, can lead to distal embolization\u2014a phenomenon described as artery-to-artery embolism. Blunt trauma from an RTA may result in an intimal tear in a cervical artery, forming an intramural hematoma and eventually a thrombus. This thrombus can either occlude the vessel locally or shed emboli that travel to distal territories, including the brainstem. This artery-to-artery embolic mechanism is a recognized cause of ischemic stroke in younger individuals following trauma. In a post-RTA patient, developing brainstem symptoms (such as vertigo, dysphagia, or ataxia) is consistent with an arterial dissection leading to embolic events in the posterior circulation. The clinical scenario strongly suggests that the underlying mechanism is related to traumatic injury of the cervical artery that subsequently embolizes. Diagnosis requires prompt imaging, with CT angiography (CTA) or MR angiography (MRA) to visualize the vessel wall and detect dissection. Differential diagnoses include direct traumatic brain injury (like hemorrhage or contusion) and cervical spine injury; however, the presence of vascular symptoms directs the focus toward arterial injury. Initial management typically involves antithrombotic therapy. The choice between antiplatelet agents and anticoagulation remains somewhat controversial, though many clinicians lean towards antiplatelet therapy based on current evidence. In pregnant patients, LMWH and low-dose aspirin are preferred due to teratogenic concerns with warfarin. The same agents are considered safe during lactation. Option A (Artery to artery) is correct because it accurately describes the mechanism wherein a thrombus originating from a traumatic dissection embolizes to affect the brainstem. Option B (Cardioembolic) is less likely in a trauma context because there is no indication of a cardiac source for emboli. 1. Always consider vertebral artery dissection in patients with head/neck trauma who present with posterior circulation symptoms. 2. Early vascular imaging is crucial for diagnosis. 3. The mechanism of artery-to-artery embolism is key in translating trauma into an ischemic event. Recent studies and guidelines emphasize the importance of early imaging with CTA/MRA in trauma patients with neurological deficits and support the use of antithrombotic therapy (either antiplatelets or anticoagulants) in the management of cervical artery dissections, with special considerations for pregnant patients.",
    "exam_year": "2021",
    "exam_type": "Part I"
  },
  {
    "question": "CT brain attached showed right pica territory infarction, asked about finding on exam?",
    "option_a": "Left side uvula deviation",
    "option_b": "Left Side Ptosis",
    "option_c": "Right body decrease sensation",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "A right PICA (Posterior Inferior Cerebellar Artery) territory infarction typically affects the lateral medulla, a region containing critical cranial nerve nuclei including the nucleus ambiguus, which is involved in palatal elevation. Infarction due to occlusion of the PICA results in ischemia of structures in the lateral medulla. When the nucleus ambiguus is compromised, particularly on the right side, the muscles of the soft palate on that side are weakened. This leads to a relative overactivity on the contralateral (left) side, pulling the uvula toward the unaffected side. Clinically, a patient with a right PICA infarct may present with signs of lateral medullary (Wallenberg) syndrome, including dysphagia, hoarseness, and loss of gag reflex. The classic neurological exam finding of uvula deviation to the left is consistent with a right-sided lesion affecting the vagal-innervated musculature of the palate. Diagnosis is generally confirmed with MRI, which clearly delineates the infarct in the PICA distribution. Differential considerations include other brainstem or cerebellar stroke syndromes, but the pattern of cranial nerve involvement helps localize the lesion to the lateral medulla. Acute treatment for ischemic stroke follows standard protocols, including consideration for thrombolytic therapy if within the therapeutic window. Secondary prevention involves the use of antiplatelet agents. In pregnant patients, aspirin is preferred, while LMWH may be used if anticoagulation is indicated, and both are considered safe during lactation. Option A (Left side uvula deviation) is correct because a right-sided lesion leads to weakness of the right palate, causing the uvula to deviate to the left. Option B (Left side Ptosis) is more aligned with sympathetic pathway involvement (Horner\u2019s syndrome) and is not a classical feature of a straightforward PICA infarct. Option C (Right body decrease sensation) is inconsistent with the typical crossed findings (ipsilateral face and contralateral body sensory loss) in lateral medullary syndrome. 1. In PICA infarcts, look for signs of lateral medullary syndrome including palatal weakness and uvula deviation. 2. Uvula deviation typically occurs away from the side of the lesion. 3. MRI is the imaging modality of choice in suspected posterior circulation strokes. Recent research supports the early use of advanced MRI techniques (including diffusion-weighted imaging) in the diagnosis of brainstem strokes. Updated guidelines also stress the importance of thorough neurological examination in localizing brainstem lesions such as those seen in PICA territory infarcts.",
    "exam_year": "2021",
    "exam_type": "Part I"
  },
  {
    "question": "Same as above Q asked about investigation?",
    "option_a": "MRI",
    "option_b": "MRV (should rule out CVT)",
    "option_c": "LP",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "In the investigation of an acute ischemic stroke, particularly one localized to a specific arterial territory such as the PICA, it is paramount to directly visualize the brain parenchyma. Magnetic Resonance Imaging (MRI) is the gold standard for detecting acute infarctions in the brain. Ischemic strokes, like those in the PICA territory, result from occlusion of an arterial supply leading to cell death in the affected region. MRI, especially diffusion-weighted imaging (DWI), is highly sensitive to these early ischemic changes. MR Venography (MRV) is designed to evaluate the cerebral venous system and is most useful when cerebral venous thrombosis (CVT) is suspected\u2014an entirely different pathologic process with distinct clinical features. For a patient exhibiting classic signs of a right PICA infarction (e.g., lateral medullary syndrome features), an MRI will confirm the arterial infarct. In contrast, CVT typically presents with symptoms such as headache, seizures, and signs of raised intracranial pressure, not with the focal deficits seen in arterial strokes. The appropriate investigation in this setting is an MRI of the brain, which provides clear visualization of the infarcted tissue. MRV should be reserved for cases where there is clinical suspicion for CVT. Lumbar puncture (LP) does not play a role in the routine evaluation of arterial strokes. After confirming the diagnosis with MRI, acute management may include thrombolytic therapy if within the therapeutic window, followed by secondary prevention with antiplatelet agents and risk factor management. In pregnant patients, the use of thrombolytics must be carefully weighed against potential risks, and aspirin is often the antiplatelet agent of choice. During lactation, both aspirin (in low doses) and other approved agents are considered safe, while warfarin is avoided in pregnancy. Option A (MRI) is the correct investigation because it accurately images the brain parenchyma and can reliably detect infarctions in the PICA distribution. Option B (MRV) is incorrect as it is designed to evaluate the venous system for conditions such as CVT, which is not the suspected pathology in this case. Option C (LP) is not indicated in evaluating an arterial stroke. 1. MRI with diffusion-weighted imaging is the investigation of choice in detecting acute ischemic strokes. 2. MRV is reserved for the assessment of cerebral venous thrombosis, which has a markedly different clinical presentation. 3. Accurate imaging is critical in determining time-sensitive stroke interventions. Current American Heart Association/American Stroke Association guidelines endorse the use of MRI (particularly DWI sequences) in the acute setting for the detection of cerebral ischemia. Recent studies also highlight the limited role of MRV in arterial strokes, reinforcing that MRV is not indicated unless CVT is specifically suspected.",
    "exam_year": "2021",
    "exam_type": "Part I"
  },
  {
    "question": "50-year-old patient, heavy smoker, hypertensive on medication, came with history of left eye visual changes & dysarthria for 10 min then resolved, asked about next?",
    "option_a": "MRI brain",
    "option_b": "CTA neck",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "This case describes a classic transient ischemic attack (TIA): a self\u2010limiting episode of neurological dysfunction caused by transient cerebral ischemia. Given the patient\u2019s vascular risk factors (hypertension and heavy smoking) and the nature of his symptoms (transient visual changes and dysarthria), the next step is to evaluate the potential vascular source of embolism. TIAs are typically due to temporary occlusion of a cerebral artery often from an embolus or in situ thrombosis over an atherosclerotic plaque. In patients with risk factors like atherosclerosis, an unstable plaque in the carotid artery may intermittently shed emboli leading to transient neurological deficits. The patient\u2019s symptoms\u2014transient visual changes (which may represent amaurosis fugax) and dysarthria\u2014are indicative of ischemia in areas supplied by the carotid circulation. The presence of such symptoms in a high-risk patient mandates urgent evaluation to stratify risk and prevent subsequent stroke. Initial evaluation of suspected TIA typically includes neuroimaging (CT or MRI) to rule out acute infarction, followed by vascular imaging. Differential diagnoses include migraine with aura, seizure-related transient deficits, and ocular causes. However, in a patient with vascular risk factors, evaluation of the carotids is paramount. Carotid imaging via CT angiography (CTA neck) or duplex ultrasound is used to identify significant stenosis. Management involves both diagnostic evaluation and secondary prevention. First-line evaluation includes brain imaging to exclude stroke and vascular imaging (CTA neck, carotid duplex) to evaluate for carotid stenosis. In addition, antiplatelet therapy (e.g., aspirin) and aggressive risk factor modification (smoking cessation, control of hypertension, statin therapy) are essential. In pregnant or lactating patients, alternative imaging modalities (like carotid duplex ultrasound) may be preferred to minimize radiation exposure, though CTA can be performed with proper shielding if necessary. Option A (MRI brain) is useful for detecting small infarcts but does not evaluate the carotid vasculature directly. Option B (CTA neck) is the most appropriate next step as it assesses the extracranial carotid arteries for atherosclerotic disease or dissection, which is critical in TIA workup. The other options are not provided and therefore are not considered. 1. TIA is a warning sign of potential future strokes\u2014prompt evaluation is crucial. 2. Vascular imaging (such as CTA neck) is indispensable to identify a treatable source of embolism. 3. Risk factor modification is a cornerstone of secondary prevention. Recent guidelines from the American Heart Association emphasize rapid vascular imaging in TIA patients to identify high-risk lesions and guide early intervention. Studies continue to support early carotid imaging as part of a comprehensive stroke prevention strategy.",
    "exam_year": "2021",
    "exam_type": "Part I"
  },
  {
    "question": "Case scenario of a patient with high NIHSS then dropped down to 6 but still has dysarthria and weakness what do next?",
    "option_a": "Give t-PA",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "This question concerns the management decision in acute ischemic stroke when there is dramatic early improvement but residual deficits persist. The key concept is that even if a patient\u2019s NIH Stroke Scale (NIHSS) improves, if disabling deficits remain, treatment with IV t-PA is still indicated. Acute ischemic stroke results from an arterial occlusion leading to brain tissue ischemia. Early reperfusion therapy (with t-PA) helps to salvage at-risk brain tissue. In some cases, spontaneous partial recanalization may occur, leading to improvement, but residual deficits (such as dysarthria and weakness) may still be significant and disabling. Despite an initial high NIHSS, the patient\u2019s improvement to an NIHSS of 6 does not eliminate the possibility of a clinically significant and disabling stroke. Dysarthria and weakness can significantly impair daily functioning. The risk of deterioration or incomplete recovery supports proceeding with reperfusion therapy in eligible patients. The diagnostic workup includes a non-contrast CT scan (to rule out hemorrhage) and clinical scoring using the NIHSS. Differential considerations include transient ischemic attack (if deficits resolve completely) versus an evolving stroke. In this case, the persistent deficits indicate a stroke that may benefit from thrombolytic therapy. According to current guidelines, IV t-PA is indicated for acute ischemic stroke within the 4.5-hour window unless contraindicated. First-line management is rapid thrombolysis with t-PA. For patients with residual disabling deficits, even after some improvement, reperfusion therapy is recommended. In pregnant patients, the use of t-PA is controversial but may be justified if benefits outweigh risks, and similarly in lactating patients, t-PA is considered relatively safe. Option A (Give t-PA) is correct because the presence of residual disabling deficits (even with an improved NIHSS of 6) qualifies the patient for thrombolytic therapy provided he is within the window and no contraindications exist. The other options (B, C, D) were not provided, making t-PA the best and only provided management option. 1. Improvement in NIHSS does not automatically preclude the use of t-PA if deficits remain disabling. 2. Even an NIHSS of 6 can represent a stroke that significantly impairs function. 3. \u2018Rapidly improving\u2019 is a relative contraindication only if the deficits are non-disabling. Recent stroke guidelines underscore that patients with \u2018rapid improvement\u2019 but residual disabling symptoms should not be excluded from thrombolysis. Updated research reinforces the benefit of t-PA in salvaging brain tissue in eligible patients, with several studies addressing the management of these borderline cases.",
    "exam_year": "2021",
    "exam_type": "Part I"
  },
  {
    "question": "Case scenario of a patient with stroke syndrome findings suggestive of lateral pons (patient has hearing problem)?",
    "option_a": "AICA",
    "option_b": "PICA",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "This case centers on lateral pontine syndrome. The involvement of auditory pathways in the lateral pons is most characteristically associated with infarction of the territory supplied by the anterior inferior cerebellar artery (AICA). An infarct in the AICA territory affects the lateral pons where important structures including the cochlear nuclei are located, leading to symptoms such as hearing loss. Damage to the adjacent neural structures may also produce deficits like facial paralysis and ataxia. In patients presenting with stroke symptoms localized to the lateral pons, the presence of hearing impairment strongly points toward an AICA infarct. This helps differentiate it from other brainstem syndromes (e.g., lateral medullary syndrome from PICA infarction) which rarely present with hearing loss. Diagnosis is supported by clinical exam and confirmed with neuroimaging (CT or MRI). Differential diagnoses include lateral medullary syndrome (PICA infarct) and other brainstem pathologies; however, the notable finding of hearing loss is more specific for AICA involvement. Acute management aligns with stroke protocols \u2013 rapid evaluation, consideration of thrombolytic therapy if within the window, and supportive care. Secondary prevention includes antiplatelets, statins, and risk factor management. In pregnancy or lactation, similar stroke guidelines apply; thrombolysis can be considered if benefits outweigh risks, with careful monitoring and multidisciplinary management. Option A (AICA) is correct because hearing loss is a hallmark of lateral pontine syndrome due to AICA infarction. Option B (PICA) is incorrect because lateral medullary syndrome from PICA infarct typically spares hearing. Options C and D were not provided. 1. AICA infarcts classically present with ipsilateral hearing loss, vertigo, and facial weakness. 2. Differentiation from lateral medullary syndrome relies heavily on the presence of auditory symptoms. 3. Accurate localization aids in optimizing management strategies. Recent neuroimaging advances have improved the diagnostic accuracy of brainstem strokes. Current guidelines continue to recommend prompt reperfusion therapy for eligible patients with posterior circulation strokes, with careful attention to clinical localization.",
    "exam_year": "2021",
    "exam_type": "Part I"
  },
  {
    "question": "Attached picture of a patient with Horner\u2019s (ptosis, miosis) came with thunderclap HA, ct brain and LP done within 4 hr, was normal!!",
    "option_a": "Pcom aneurysm rupture",
    "option_b": "RCVS",
    "option_c": "ICA dissection",
    "option_d": "",
    "option_e": "",
    "correct_answer": "C",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "This clinical scenario describes a patient who presents with thunderclap headache and signs of Horner\u2019s syndrome (ptosis and miosis). These features are highly suggestive of an internal carotid artery (ICA) dissection, a known cause of such presentations. ICA dissection occurs when a tear in the arterial wall allows blood to enter and split the layers of the vessel wall, often compromising the sympathetic plexus that runs along the artery. This results in Horner\u2019s syndrome. The sudden, severe headache (\u201cthunderclap headache\u201d) is a common presenting feature. Patients with ICA dissection frequently present with a unilateral headache, neck pain, and ipsilateral Horner\u2019s syndrome. The normal CT scan and lumbar puncture (LP) help rule out subarachnoid hemorrhage, making ICA dissection the most likely diagnosis in this setting. Although the initial CT brain and LP are normal, further evaluation with CT angiography (or MR angiography) of the neck is essential to identify the dissection. Differentials include ruptured aneurysm (e.g., Pcom aneurysm rupture which typically shows hemorrhage on CT) and reversible cerebral vasoconstriction syndrome (RCVS, which usually lacks Horner\u2019s syndrome). Management of ICA dissection involves antithrombotic therapy (either antiplatelet agents or anticoagulation) to prevent thromboembolic complications. This is typically the first-line treatment. In cases where symptoms deteriorate or if there is evidence of compromised cerebral blood flow, endovascular repair may be considered. For pregnant or lactating patients, antithrombotic therapies (especially low-dose aspirin) are used with caution, considering the safety profiles and risk\u2013benefit assessments in these populations. Option A (Pcom aneurysm rupture) would generally produce subarachnoid hemorrhage with positive CT/LP findings. Option B (RCVS) usually causes thunderclap headache without the classic finding of Horner\u2019s syndrome. Option C (ICA dissection) is correct because it best explains the combination of thunderclap headache and Horner\u2019s syndrome in the context of normal CT/LP findings. 1. Horner\u2019s syndrome in the setting of a thunderclap headache is a red flag for carotid dissection. 2. Normal CT and LP do not rule out ICA dissection; vascular imaging is required. 3. Early diagnosis and treatment with antithrombotic therapy can reduce the risk of subsequent stroke. Current guidelines and recent studies continue to support the use of antithrombotic therapy as first-line management for cervical artery dissection. Advances in vascular imaging have significantly improved early detection, and updated consensus statements provide guidance on management in special populations such as pregnant and lactating patients.",
    "exam_year": "2021",
    "exam_type": "Part I"
  },
  {
    "question": "SAH female young patient with symptomatic PComm aneurysm next?",
    "option_a": "Clipping",
    "option_b": "Coiling",
    "option_c": "Discharge",
    "option_d": "Medical treatment",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "Aneurysmal subarachnoid hemorrhage (SAH) most often results from rupture of a cerebral aneurysm. In this case, a young female with a symptomatic posterior communicating artery (PComm) aneurysm presents a scenario where the key step is to secure the aneurysm to prevent rebleeding. Two primary methods are available: surgical clipping and endovascular coiling. The rupture of an aneurysm leads to blood extravasation into the subarachnoid space, provoking a cascade of events including increased intracranial pressure, inflammation, and vasospasm due to breakdown products of blood. The PComm aneurysm\u2019s location often makes it amenable to endovascular intervention because modern coiling techniques can effectively isolate the aneurysm from the circulation with lower invasiveness. Patients with SAH typically present with a sudden, severe headache ('thunderclap headache'), along with signs of meningeal irritation and possible focal deficits depending on the hemorrhage location. Securing the aneurysm rapidly is critical to reduce the high risk of rebleeding in the acute phase. Initial diagnosis is made with a non-contrast CT scan of the head to identify hemorrhage. Following this, CT angiography or digital subtraction angiography is employed to localize and characterize the aneurysm, distinguishing it from other vascular lesions and guiding the treatment plan. Current guidelines (supported by studies such as ISAT) favor endovascular coiling for many aneurysms due to its less invasive nature and lower immediate morbidity compared to clipping. First-line treatment in a suitable aneurysm is coiling, provided the aneurysm morphology supports it. In women of child\u2010bearing age, careful attention is needed with radiation exposure and contrast use; multidisciplinary input ensures that pregnancy (or potential pregnancy) is managed appropriately. Second-line or alternative treatment is surgical clipping, which may be considered based on aneurysm anatomy or if endovascular expertise is unavailable. Option A (Clipping) is a valid treatment modality but is more invasive; Option B (Coiling) is the chosen and correct option as it is typically preferred when the aneurysm\u2019s morphology is favorable; Option C (Discharge) is inappropriate given the life\u2010threatening nature of aneurysmal SAH; Option D (Medical treatment) is inadequate since active intervention is required to prevent rebleeding. 1) Nimodipine is used in SAH for vasospasm prophylaxis. 2) Endovascular coiling is less invasive and, in suitable aneurysms, has been shown to yield better short\u2010term outcomes. 3) Multidisciplinary evaluation is essential in determining the best approach for aneurysm management. Recent updates and evidence from the International Subarachnoid Aneurysm Trial (ISAT) and subsequent studies support the use of endovascular coiling in anatomically favorable aneurysms. Advancements in endovascular technology continue to refine patient selection and improve outcomes.",
    "exam_year": "2021",
    "exam_type": "Part I"
  }
]